<DOC>
	<DOCNO>NCT03022201</DOCNO>
	<brief_summary>This study evaluate therapeutic efficacy safety DA-9701 domperidone patient Parkinson 's disease</brief_summary>
	<brief_title>Comparing Therapeutic Efficacy Safety DA-9701 With Domperidone Patients With Parkinson 's Disease</brief_title>
	<detailed_description>To prevent nausea vomit induced anti-parkinsonian drug , prokinetic drug frequently prescribe patient Parkinson 's disease ( PD ) . Additionally , evidence prokinetics might improve PD symptom fluctuation . From background , investigator evaluate therapeutic efficacy safety DA-9701 PD patient . In study , 40 patient enrol randomly allocate 1:1 receive either domperidone DA-9701 . The gastric function study participant evaluate use MRI technique 4 week treatment . The study participant also subject complete gastrointestinal symptom diary treatment period . In addition , plasma levodopa concentration determine 30 minute dose administration treatment .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>subject diagnose spontaneous parkinsonism United Kingdom ( UK ) Parkinson 's Disease Society Brain Bank criterion subject able explain symptom experience complete relevant assessment exam include questionaires subject understand purpose protocol study agree participate study subject experience psychiatrical disorder cognitive behavioral disorder subject prokinetics unable cease medication subject present neurological disorder influence gastrointestinal mobility subject present gastrointestinal condition influence gastrointestinal mobility subject history gastrectomy colectomy subject unable receive complete course medication due metabolic disorder subject diagnose parkinson plus syndrome subject unable undergo MRI scan safety reason due claustrophobia certain device cardiac pacemaker aneurysm clip</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Motilitone</keyword>
</DOC>